A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease
Titel:
A Phase II Study of BTI-322, a Monoclonal Anti-CD2 Antibody, for Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease
Auteur:
Przepiorka, Donna Phillips, Gordon L. Ratanatharathorn, Voravit Cottler-Fox, Michele Sehn, Laurie H. Antin, Joseph H. LeBherz, Donna Awwad, Michel Hope, James McClain, J. Bruce